Analgesic efficacy of Pericapsular Nerve Group (PENG) block compared with Fascia Iliaca Block (FIB) in the elderly patient with fracture of the proximal femur in the emergency room. A randomised controlled trial

被引:1
|
作者
Marrone, F. [1 ]
Graziano, G. [2 ]
Paventi, S. [1 ]
Tomei, M. [1 ]
Gucciardino, P. [1 ]
Bosco, M. [1 ]
机构
[1] ASL Roma 1, Santo Spirito Hosp, Rome, Italy
[2] Ctr Outcomes Res & Clin Epidemiol CORESEARCH, Pescara, Italy
来源
关键词
PENG block; Fascia iliaca block; US-guided blocks; Trauma Anaesthesia; HIP FRACTURE; REGIONAL ANESTHESIA;
D O I
10.1016/j.redar.2022.10.002
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Introduction and objectives: Data on the efficacy of PENG (Pericapsular Nerve Group) block in hip trauma pain are scarce. We hypothesized that PENG block was more effective than infra-inguinal ultrasound-guided FIB (Fascia Iliaca block) for pain control in patients aged 65 years or older presenting in the emergency room (ER) with traumatic proximal femoral fracture.Materials and methods: We conducted an exploratory, double-blind, randomized controlled trial. One anaesthesiologist performed the block and another assessed outcomes.Patients were randomly allocated to the PENG group (20 ml ropivacaine 0.375%) or the infrainguinal FIB group (40 ml ropivacaine 0.2%). Standard hypothesis tests (t test or chi(2) test) were performed to analyse baseline characteristics and outcome parameters. The primary end-point of the study was analgesic success, defined as << NRS pain score <= 4 >> 30 min after blockade, with PENG vs to FIB. Secondary outcomes were pain at rest (<< pain at rest NRS score <= 4 >> 30 min after blockade), duration of analgesia (time to first request for analgesia), need for rescue medication in case of block failure, and complications during blockade.Results: After obtaining ethical committee approval and written informed consent, 60 patients were included.The primary endpoint was achieved in 16 out of 30 patients (53.3%) in the PENG group and in 15 out of 28 patients (53.6%) in the FIB group. Comparison between groups did not show superiority of the PENG vs FIB (p = 0.98).Conclusions: PENG block does not provide better pain than FIB in proximal femoral fracture in elderly patients treated in the ER.
引用
收藏
页码:501 / 508
页数:8
相关论文
共 50 条
  • [31] Reply to: Pericapsular nerve group (PENG) block for early pain management of elderly patients with hip fracture: a single-center double-blind randomized controlled trial
    Piccolo, Claudia Valeria
    Skerritt, Conor John
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2024, 49 (04) : 306 - 306
  • [32] Evaluation of Ultrasound-guided Pre-emptive Fascia Iliaca Compartment Block for Postoperative Analgesia in Femur and Hip Fracture Surgeries: A Randomised Controlled Trial
    Sahithi, Tomurthy
    Venkatraman, Rajagopalan
    Swetharamani, Chinnappan K.
    Karthik, Krishnamoorthy
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (06) : UC29 - UC32
  • [33] Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial
    Pascarella, G.
    Costa, F.
    Del Buono, R.
    Pulitano, R.
    Strumia, A.
    Piliego, C.
    De Quattro, E.
    Cataldo, R.
    Agro, F. E.
    Carassiti, M.
    ANAESTHESIA, 2021, 76 (11) : 1492 - 1498
  • [34] Efficacy of Supplemental Ultrasound-Guided Pericapsular Nerve Group (PENG) Block Combined with Lateral Femoral Cutaneous Nerve Block in Patients Receiving Local Infiltration Analgesia after Hip Fracture Surgery: A Prospective Randomized Controlled Trial
    Yoo, Seung-hee
    Lee, Min-jin
    Beak, Min-hyouk
    Kim, Won-joong
    MEDICINA-LITHUANIA, 2024, 60 (02):
  • [35] Preoperative Analgesia Efficacy of Liposomal Bupivacaine Following Pericapsular Nerve Group (PENG) Block in Patients with Hip Fracture: A Randomized Controlled Observer-Blinded Study
    Peng, Haobin
    Wen, Jiajun
    Chen, Manli
    Xia, Zhengyuan
    Jiang, Ying
    Xie, Kaiqi
    Huang, Weitao
    Cui, Bangsheng
    Li, Peixing
    Zhang, Yiwen
    Wu, Xianping
    PAIN AND THERAPY, 2025, 14 (01) : 283 - 296
  • [36] The effect of pericapsular nerve group (PENG) block on postoperative analgesia in elderly patients who underwent proximal femoral nail anti-rotation surgery: a prospective, randomized-controlled trial
    Wu, Han
    Yang, Rui-zhi
    Chen, Yu
    Chen, Ting
    Qiu, Liang-Cheng
    Wu, Xiao-Dan
    BMC ANESTHESIOLOGY, 2024, 24 (01):
  • [37] Pericapsular nerve group (PENG) block provides improved short-term analgesia compared with the femoral nerve block in hip fracture surgery: a single-center double-blinded randomized comparative trial
    Lin, D-Yin
    Morrison, Craig
    Brown, Brigid
    Saies, Alexander Andrew
    Pawar, Reshma
    Vermeulen, Marthinus
    Anderson, Stewart Robert
    Lee, Tsai Sheng
    Doornberg, Job
    Kroon, Hidde Maarten
    Jaarsma, Ruurd Lukas
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2021, 46 (05) : 398 - 403
  • [38] Comparing Analgesic Effect of Intravenous Fentanyl, Femoral Nerve Block and Fascia Iliaca Block During Spinal Anesthesia Positioning in Elective Adult Patients Undergoing Femoral Fracture Surgery: a Randomized Controlled Trial
    Bantie, Melaku
    Mola, Simeneh
    Girma, Timsel
    Aweke, Zemedu
    Neme, Derartu
    Zemedkun, Abebayehu
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 3139 - 3146
  • [39] Quality of recovery after pericapsular nerve group (PENG) block for primary total hip arthroplasty under spinal anaesthesia: a randomised controlled observer-blinded trial
    Kukreja, Promil
    Uppal, Vishal
    Kofskey, Alexander M.
    Feinstein, Joel
    Northern, Theresa
    Davis, Camille
    Morgan, Charity J.
    Kalagara, Hari
    BRITISH JOURNAL OF ANAESTHESIA, 2023, 130 (06) : 773 - 779
  • [40] Effects of Different Volumes of Ropivacaine for Pericapsular Nerve Group Block on Incidence of Quadriceps Weakness and Analgesic Efficacy Following Hip Arthroplasty: A Randomized Controlled Trial
    Wen, Huaichang
    Zhang, Weihua
    Wang, Yi
    Lu, Meijing
    PAIN AND THERAPY, 2024, 13 (03) : 533 - 541